THL Partners (“THL”), a premier private equity firm investing in middle market growth companies, announces the entry into a definitive agreement to acquire Headlands Research (“Headlands” or “the Company”), a leading multinational network of clinical trial sites, from funds managed by leading global investment firm KKR. Headlands operates an integrated network of clinical trial sites across North America, conducting trials across key therapeutic areas, including central nervous system (“CNS”) disorders, vaccines, and metabolic diseases. KKR founded Headlands in 2018 via its Health Care Strategic Growth Fund to transform the clinical trial site industry and improve the throughput and inclusivity of clinical trials.
Read the full article: THL Announces Agreement to Acquire Headlands Research from KKR //
Source: https://www.businesswire.com/news/home/20250814383571/en/THL-Announces-Agreement-to-Acquire-Headlands-Research-from-KKR